ClinicalTrials.Veeva

Menu

Ultrasound Capsule Endoscopy for Esophagus Examination

N

Naval Military Medical University

Status

Unknown

Conditions

Esophageal Diseases

Treatments

Other: ultrasound capsule endoscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT05054933
Ultrasound CE

Details and patient eligibility

About

The aim of this pilot study is to assess the feasibility and safety of the clinical application of ultrasound capsule endoscopy in esophageal examination compared with conventional endoscopic ultrasound examination.

Full description

Wireless capsule endoscopy has opened a new era by enabling remote diagnostic assessment of the gastrointestinal tract in a painless procedure. However, most commercially available devices only utilise optical imaging to examine the GI wall surface. Using this sensing modality, pathology within the GI wall cannot be detected. Micro-ultrasound (mUS) using high-frequency (>20 MHz) ultrasound can provide a means of transmural or cross-sectional image of the GI tract. Depth of imaging is approximately 10 mm with a resolution of between 40-120 μm that is sufficient to differentiate between subsurface histologic layers of the various regions of the GI tract. Ultrasound capsule endoscopy (USCE) uses a capsule equipped with mUS transducers that are capable of imaging below the GI wall surface, offering thereby a complementary sensing technique to optical imaging capsule endoscopy. In this work, a USCE device integrated with a 40 MHz ultrasonic transducer was developed to capture a full 360˚ image of the lumen. Previous animal studies of two anaesthetised Landrace pigs have demonstrated the effectiveness of the device. The reconstructed images demonstrate clear layer differentiation of the lumen wall. The tissue thicknesses measured from the B-scan images show good agreement with ex vivo images from the literature. The aim of this pilot study is to assess the feasibility and safety of the clinical application of ultrasound capsule endoscopy in esophageal examination compared with conventional endoscopic ultrasound examination.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Participants aged 18 years or older.
  2. Both inpatients and outpatients.
  3. Healthy volunteers or patients with suspected esophageal disease
  4. Able to provide informed consent.

Exclusion criteria

  1. known or suspected complex history of gastrointestinal obstruction, stenosis or fistula.
  2. dysphagia.
  3. known or suspected possibility of active bleeding of digestive tract.
  4. Pregnancy or suspected pregnancy..
  5. Patients who have participated in or are participating in other clinical trials within three months.
  6. Life-threatening conditions.
  7. other circumstances that doctors consider inappropriate for the study.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

ultrasound capsule endoscopy examination
Other group
Description:
Healthy volunteers or patients with suspected esophageal disease will be enrolled to take ultrasound capsule endoscopy examination followed by conventional endoscopic ultrasound examination within 2 weeks.
Treatment:
Other: ultrasound capsule endoscopy

Trial contacts and locations

1

Loading...

Central trial contact

Zhuan Liao, Professor; Xi Jiang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems